scispace - formally typeset
Open AccessJournal ArticleDOI

Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans

TLDR
This is the first report linking CREB3L1 to human recessive OI, thereby expanding the OI gene spectrum and detecting a homozygous genomic deletion of CREB 3L1 in a family with severe OI.
Abstract
Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous brittle bone disorder. Whereas dominant OI is mostly due to heterozygous mutations in either COL1A1 or COL1A2, encoding type I procollagen, recessive OI is caused by biallelic mutations in genes encoding proteins involved in type I procollagen processing or chaperoning. Hitherto, some OI cases remain molecularly unexplained. We detected a homozygous genomic deletion of CREB3L1 in a family with severe OI. CREB3L1 encodes OASIS, an endoplasmic reticulum-stress transducer that regulates type I procollagen expression during murine bone formation. This is the first report linking CREB3L1 to human recessive OI, thereby expanding the OI gene spectrum.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment

TL;DR: The new OI nomenclature and the pre‐and postnatal severity assessment introduced in this review, emphasize the importance of phenotyping in order to diagnose, classify, and assess severity of OI.
Journal ArticleDOI

Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta.

TL;DR: The data reported here may be helpful to predict phenotype, and describes for the first time the genetic epidemiology in >95% of an entire OI population.
Journal ArticleDOI

Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.

TL;DR: Identification of these multiple causative defects has provided crucial information for accurate genetic counseling, inspired a recently proposed functional grouping of osteogenesis imperfecta types by shared mechanism to simplify current nosology, and has prodded investigations into common pathways in osteogenesis perfecta.
Journal ArticleDOI

Osteogenesis imperfecta – A clinical update

TL;DR: Intravenous bisphosphonates are the most widely used intervention, having significant favorable effects regarding areal bone mineral density and vertebral reshaping following fractures in growing children, but more research is needed to delineate the best therapeutic approach in this heterogeneous disease.
References
More filters
Journal ArticleDOI

qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data

TL;DR: Advanced and universally applicable models for relative quantification and inter-run calibration with proper error propagation along the entire calculation track are outlined in qBase, a free program for the management and automated analysis of qPCR data.
Journal ArticleDOI

Detection of large-scale variation in the human genome.

TL;DR: This article identified 255 loci across the human genome that contain genomic imbalances among unrelated individuals, and revealed that half of these regions overlap with genes, and many coincide with segmental duplications or gaps in human genome assembly.
Journal ArticleDOI

DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources

TL;DR: An interactive web-based database called DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources) which incorporates a suite of tools designed to aid the interpretation of submicroscopic chromosomal imbalance, inversions, and translocations.
Journal ArticleDOI

New perspectives on osteogenesis imperfecta.

TL;DR: Clinical management of osteogenesis imperfecta is multidisciplinary, encompassing substantial progress in physical rehabilitation and surgical procedures, management of hearing, dental and pulmonary abnormalities, as well as drugs, such as bisphosphonates and recombinant human growth hormone.
Related Papers (5)